# ScoreItem: Bra√ßo direito contra√≠do (cm)

**ID:** `c77cedd3-2800-7f52-b0eb-c1daf5da33fa`
**FullName:** Bra√ßo direito contra√≠do (cm) (Composi√ß√£o corporal - Atual)

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 11 artigos
- Avg Similarity: 0.523

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-7f52-b0eb-c1daf5da33fa`.**

```json
{
  "score_item_id": "c77cedd3-2800-7f52-b0eb-c1daf5da33fa",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 0,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Nota:** `points` deve ser `0` neste item ‚Äî n√£o calcule pontua√ß√£o.

---

### Contexto Cient√≠fico

**ScoreItem:** Bra√ßo direito contra√≠do (cm) (Composi√ß√£o corporal - Atual)

**30 chunks de 11 artigos (avg similarity: 0.523)**

### Chunk 1/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.575

otrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChinesepopulation.Wepreviouslypub-lishedarelevantarticle[16].ManystudiesshowedthatvitaminDwascloselyrelatedtomusclesandbones.Notably,ourresultsshowedthatexcludingtheinfluenceofvitaminD,oxytocinwasalsoassociatedwithosteo-porosis,andfollistatinandDHEAwereassociatedwithsarcopenia.Inourstudy,milkconsumption(<50mL/dayvs.‚â•250mL/day)(OR6.32;95%CI1.04‚Äì38.29;p=0.045)wasassociatedwithsarcopenia.Thereasonisthatmilkcontainsnutrients,especiallywheyprotein,thatmaybemyoprotective.Onetrialinvestigatedtheeffectofaddingmilkproteintothehabitualdietonskeletalmusclemass,strength,andphysicalperformanceinMexicanelderlyindividualswithoutsarcopenia.Theresultsshowedthatconsumptionmayreducetheriskofsarco-peniabyimprovingskeletalmusclemassduetotheadditionofnutrient-richdairyproteinstothehabitualdiet[36].However,curr

---

### Chunk 2/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.568

rcopeniawasbasedonappendicularskeletalmusclemass(ASM;kg)measurementsandwasnormalizedforheight[ASMI(AppendicularSkeletalMuscleMassIndex)=ASM/height2(kg/m2)].SarcopeniawasdefinedasmeetingtheAWGScriteria[18]andcategorizedusingthefollowingthresholdvalues:(1)LowmusclemasswasASMI<5.4kg/m2;(2)Lowmusclestrengthwashandgripstrength<18kg;and(3)Poorphysicalperformancewasgaitspeeds<0.8m/sbya6-mwalktest.AccordingtotheWorldHealthOrganization(WHO)definition[15],osteoporosiswasdefinedasaT-scoreofBMD‚â§‚àí2.5forvertebral,femurneckortotalhip,havingexperiencedalow-traumahiporvertebralfracture,orhavingosteopeniabyBMDwhosustainedalow-traumaproximalhumerus,pelvis,ordistalforearmfracture.Osteosarcopeniaisthecombinationofsarcope-niaandosteoporosis.LaboratoryanalysesSerumsampleswerecollectedbetween0700and0900haftera10-hfast,andfreshlyseparatedserumwasdi-videdinto0.5-mlaliquotsandstoredat‚àí80¬∞C.Serumlevelsoffollistatin,myostatin,BDNFandoxytocinweremeasuredusingQuantikineELISA(R&DSystems,Min-neapolis,MN,USA),wi

---

### Chunk 3/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIX (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.553

g/kg) e pr√°tica de exerc√≠cios de resist√™ncia para preservar massa muscular.
- [ ] 3. Todos os profissionais: Em doen√ßas cr√¥nicas sem causa org√¢nica clara ou com m√° resposta ao tratamento, investigar ativamente traumas de inf√¢ncia, estresse cr√¥nico e quest√µes emocionais n√£o resolvidas como poss√≠vel "causa primeira".
- [ ] 4. Terapeutas e psic√≥logos: Adotar "terapia de precis√£o", utilizando m√∫ltiplas ferramentas e combinando diferentes abordagens terap√™uticas para personalizar o tratamento e focar em resultados mensur√°veis, em vez de seguir uma √∫nica linha te√≥rica por longos per√≠odos.
- [ ] 5. Estudo pessoal: Pesquisar o conceito de "causa primeira" de Arist√≥teles para aprofundar a l√≥gica de buscar a origem dos problemas.
- [ ] 6. Estudo pessoal: Ler o livro de Bruce Lipton sobre a conex√£o entre mente e doen√ßas f√≠sicas.

---

## SOAP

> Data e Hora: 2025-11-17 16:33:53
> Paciente: 
> Diagn√≥stico:

## Hist√≥rico do Diagn√≥stico:
1. Hist√≥rico M√©dico: 
2.

---

### Chunk 4/30
**Article:** Bioqu√≠mica Metab√≥lica nos Exerc√≠cios - Parte III (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.547

do-hipotireoidismo).
- Hipertrofia invi√°vel sob catabolismo salvo interven√ß√µes hormonais n√£o-mTOR com resultados limitados.
### 15. Ferramentas de controle: limiares, zonas e FIT
- Avaliar no esporte real; definir limiar via lactato e prescrever supra-limiar (acidose controlada) ou FatMax (entre 1¬∫ e 2¬∫ limiar) para mobiliza√ß√£o de gordura sem excessiva acidose.
- Framework FIT: frequ√™ncia, intensidade, tipo e tempo; monitorar FC, estado √°cido-base, marcadores de dano muscular, fontes energ√©ticas e risco de overtraining.
### 16. Estrat√©gia cl√≠nica integrativa e acompanhamento
- Basear-se na hist√≥ria cl√≠nica, nutri√ß√£o, bioqu√≠mica/metabolismo, estilo de vida, equil√≠brio hormonal.
- Iniciar com exames simples (sangue, bioimped√¢ncia), aplicar interven√ß√µes personalizadas e reavaliar em 1‚Äì2 meses, mantendo ciclo de melhoria cont√≠nua.
## ‚ùì Perguntas
- [Inserir Pergunta/Confus√£o]
## üìö Tarefas/Assignments
- [ ] 1.

---

### Chunk 5/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.544

ResClinPract.2017;11(2):177‚Äì87.https://doi.org/10.1016/j.orcp.2016.04.003.4.PicettiD,FosterS,PangleAK,SchraderA,GeorgeM,WeiJY,etal.Hydrationhealthliteracyintheelderly.NutrHealthyAging.2017;4(3):227‚Äì37.https://doi.org/10.3233/NHA-170026.5.CurcioF,FerroG,BasileC,LiguoriI,ParrellaP,PirozziF,etal.Biomarkersinsarcopenia:amultifactorialapproach.ExpGerontol.2016;85:1‚Äì8.https://doi.org/10.1016/j.exger.2016.09.007.6.EastellR,SzulcP.Useofboneturnovermarkersinpostmenopausalosteoporosis.LancetDiabetesEndocrinol.2017;5(11):908‚Äì23.https://doi.org/10.1016/S2213-8587(17)30184-5.7.McPherronAC,LawlerAM,LeeSJ.RegulationofskeletalmusclemassinmicebyanewTGF-betasuperfamilymember.Nature.1997;387:83‚Äì90.8.FifeE,KostkaJ,Kroc≈Å,GuligowskaA,Pig≈ÇowskaM,So≈ÇtysikB,etal.Relationshipofmusclefunctiontocirculatingmyostatin,follistatinandGDF11inolderwomenandmen.BMCGeriatr.2018;18(1):200.https://doi.org/10.1186/s12877-018-0888-y.9.ChoiK,JangHY,AhnJM,HwangSH,ChungJW,ChoiYS,etal.Theassociationoftheserumlevelsofm

---

### Chunk 6/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.540

rg/10.1111/joim.12369.16.ChengQ,DuY,HongW,TangW,LiH,ChenM,etal.Factorsassociatedtoserum25-hydroxyvitaminDlevelsamongolderadultpopulationsinurbanandsuburbancommunitiesinShanghai,China.BMCGeriatrics.2017;17(1):246.https://doi.org/10.1186/s12877-017-0632-z.17.Chinesenutritionsociety.Expertconsensusonnutritionandexercisemanagementinpatientswithprimaryosteoporosis.ChineseJEndocrinolMetab.2020;36(8):643‚Äì53.18.ChenL,LiuL,WooJ,etal.SarcopeniainAsia:consensusreportoftheAsianworkingGroupforSarcopenia.JAmMedDirAssoc.2014;15(2):95‚Äì101.https://doi.org/10.1016/j.jamda.2013.11.025.19.LiawF,KaoT,FangW,etal.Increasedfollistatinassociatedwithdecreasedgaitspeedamongoldadults.EurJClinInvestig.2016;46(4):321‚Äì7.https://doi.org/10.1111/eci.12595.20.IskenderianA,LiuN,DengQ,etal.Myostatinandactivinblockadebyengineeredfollistatinresultsinhypertrophyandimprovesdystrophicpathologyinmdxmousemorethanmyostatinblockadealone.SkeletMuscle.2018;8(1):34.21.ConsittLA,ClarkBC.TheviciouscycleofMyostatinsignalinginSarc

---

### Chunk 7/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.535

Bonemineraldensity,CTXC-telopeptidecollagencrosslinksDuetal.BMCGeriatrics         (2021) 21:542 Page6of10

fourgroupsofpostmenopausalwomenwithdifferentbonemusclestatusesandanalyzedtherelationshipsofbiomarkerswiththeriskofosteoporosisandsarcopenia.Theresultsshowedthatelevatedoxytocinlevelswereas-sociatedwithareducedriskofosteoporosis,andele-vatedDHEAlevelswereassociatedwithareducedriskofsarcopenia.However,elevatedfollistatinlevelswereassociatedwithanincreasedriskofsarcopenia.ThecurrentstudyfoundthatDHEAandoxytocinweresig-nificantlylowerinpostmenopausalwomenwithahis-toryoffragilityfracturecomparedtowomenwithoutfracture(datanotshown).Therefore,serumDHEAandfollistatinmaybebiomarkersofsarcopenia,andserumoxytocinmaybeabiomarkerofosteoporosis.Severalstudiesshowedthatphysicalexerciseinflu-encedserumlevelsoffollistatinandDHEA[33‚Äì35].Ourresultsshowedthatpostmenopausalwomenwith-outosteoporosis/sarcopeniaperformedhigherexerciselevelsthanwomenwithosteoporosis/sarcopenia.Fortheseresults,weconsider

---

### Chunk 8/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.529

itivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwithFife[8],whoreportedthatcirculatingmyostatinandfollistatinwerenegativelyassociatedwithmusclemassandfunctioninelderlyDuetal.BMCGeriatrics         (2021) 21:542 Page4of10

women.Myostatinisamainnegativeregulatorofskel-etalmusclegrowth,andfollistatinisastronginhibitorofmyostatin-mediatedmusclewastingthatincreasesmusclemassandmuscleregenerationandmodulatesbonemetabolismbyaffectingactivin/myostatinsignaling.However,follistatinlevelsnegativelycorrelatedwithmusclemassinourstudy.Theaccelerator-brakehypothesismayexplainthisphenomenon[19].Highfol-listatinexpressionhasbeenobservedinresponsetounfavorablemetabolicenvironments,whichmaybe
Table1DescriptivecharacteristicsofthestudiedpopulationVariableAge<65(n=171)65‚â§Age<75(n=185)75‚â§Age(n=122)PvalueAge(years)58.0¬±4.069.21¬±2.979.8¬±3.6<0.001Ageofmeno

---

### Chunk 9/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.528

osesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecreasedsignificantlydecreasedaftergastricsurgery,andinsulinresistancewassignificantlyimproved[23].Thisevidencesupportsthehypothesisthatobesityleadstoanincreaseinmyostatin,whichimpairsskeletalmusclehealth.Themainstrengthofthecurrentstudywasthatitsimultaneouslyconsideredtherelationshipbetweensev-eralbiomarkers,includingmyostatin,follistatin,oxyto-cin,BDNF,DHEA,T2andE2,andosteoporosisand/orsarcopeniainthesamestudypopulation.Therefore,thedegreeofcorrelationsbetweendifferentbiomarkersandboneandmusclewerecompared.Forthebiomarkersrelatedtosexhormones,ourstudyshowedthatDHEAwaspositivelyrelatedtohandgripandgaitspeed.Furtherresultsshowedthatpostmeno-pausalwomenwithsarcopeniaweremorelikelytohavehigherDHEAlevels.However,T2andE2werenotre-latedtomusclemass,gripstrengthorgaitspeed.Theseresultssuggestedthat

---

### Chunk 10/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.526

average‚â•210min/week;lowlevel<30min/dayoranaverage<210min/week;andnoexercise,whichwasnotperforminganyofthedefinedexercisesforover1year.2)Milkconsumptionwasassessedbasedonthefollowingthreelevels:highlevel‚â•250mL/day;lowlevel<250mL/daybut‚â•50mL/day;andnoconsumption<50mL/day.3)GripstrengthmeasurementAdigitalhandgripdynamometer(TakeiScientificIn-struments,Niigata,Japan)wasusedtodetectgripstrength.Theparticipantheldthedynamometerupwithherelbowjointata90-degreeangleandsqueezedthegripmeasurementmechanismashardasshecouldwhilewatchingthescreenforademonstration.Thetestwastypicallyperformedthreetimeswitheachhand,andthehighestvaluerepresentedtheresult.6-MetergaitspeedThe6-mgaitspeedwascompletedaccordingtoAWGS.Thesubjectplacedhertoesatthestartinglineofa6-mcoursethatwasclearlydemarcatedwithredtapeandwalkedatnormalcomfortablewalkingspeed.Ahand-heldtimerwasstartedwhenthesubjectedliftedonefoot,anditwasstoppedwhenoneofthesubjects‚Äôfeetstruckthegroundcompletelybeyondthefinishline.Thisprocesswasperfor

---

### Chunk 11/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.523

rethanonefracture.Toanalyzethechangesinvariousindicatorswithaging,subjectsweredividedintothreegroups:age65,65‚â§age<75,and75‚â§age.Gripstrength,gaitspeed,serumlevelsofDHEA,oxytocin,BMDoffemoralneckandtotalhip,andleanmassdecreasedsignificantlywithaging.Historyoffragil-ityfractureandserumlevelofT2increasedsignificantlywithage.Withincreasingage,theamountofphysicalexerciseandmilkconsumptiondecreasedsignificantly.Associationofserumbiomarkerswithbonemass,musclemassormusclestrengthadjustedforageStepwisemultivariatelinearregressionwasperformedtoassessthecorrelationbetweenbiomarkersandbonemass,musclemassandstrengthadjustedforage.TheresultsshowedthatDHEAwaspositivelyrelatedtohandgrip(Œ≤=0.403,p=0.041)andgaitspeed(Œ≤=0.58,p=0.004).Follistatin(Œ≤=‚àí0.28,p=0.01)wasnegativelyrelatedtoleanmass,andoxytocin(Œ≤=0.35,p=0.036)waspositivelyrelatedtoleanmass.Myostatin(Œ≤=0.92,p=0.021)waspositivelyrelatedtofatmass.Myostatin(Œ≤=‚àí0.31,p=0.032)andfollistatin(Œ≤=‚àí0.48,p=0.042)werenegativelyassociatedwithASM

---

### Chunk 12/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.521

.4%forCTXandbelow2.6and4.1%forP1NP,below2.7and6.5%forPTH,andbelow7.8and10.7%for25(OH)D.StatisticsSPSSv23(SPSSInc.,Chicago,IL,USA)wasusedtoanalyzethedata.KolmogorovSmirnovmethodwasusedtotestthenormaldistributionofdata.Continuousvari-ableswereexpressedasthemeanswithstandarddevi-ation,medianwithinterquartilerange(25‚Äì75%),andclassificationvariableswereexpressedaspercentages.DifferencesbetweengroupswereanalyzedusingANOVA,Kruskal-WallisHtestorPearson‚Äôschi-squaredDuetal.BMCGeriatrics         (2021) 21:542 Page3of10

testforcontinuousandcategoricalvariables,respect-ively.AftertheresidualwastestedbyExplore,multivari-atelinearregressionmodelswereconstructedtoanalyzethecorrelationbetweendependentvariables,suchasgripstrength,gaitspeed,leanmass,fatmass,ASMI,bonemass,andindependentcontinuouspredictors,suchasserummyokines,sexhormones,andboneturnovermarkers.Associationsbetweenhistoryoffragilityfrac-ture,lifestyle,serumbiomarkersandosteoporosisandsarcopeniawereanalyzedusinglogisticregressionana-lys

---

### Chunk 13/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.520

I:Appendicularskeletalmassindex;AWGS:AsianWorkingGroupforSarcopenia;BDNF:Brain-derivedneurotrophicfactor;BMD:Bonemineraldensity;BMI:Bodymassindex;CI:Confidenceintervals;COPD:Chronicobstructivepulmonarydisease;CT:Computedtomography;CTX:C-telopeptidecollagencrosslinks;CV:Coefficientsofvariance;DHEA:Dehydroepiandrosterone;DXA:DualenergyX-rayabsorptiometry;E2:Estradiol;FSH:Folliclestimulatinghormone;LH:Luteinizinghormone;MRI:Magneticresonanceimaging;OR:Oddsratios;P1NP:N-terminalpropeptideoftype1collagen;PTH:Parathyroidhormone;SHBG:Sexhormone-bindingglobulin;SPPB:Shortphysicalperformancebattery;T2:Testosterone;TGF-Œ≤:Transforminggrowthfactor-beta;WHO:WorldHealthOrganization
Table4Correlationofhistoryoffragilefracture,lifestyleandserumbiomarkerswithosteoporosisorsarcopeniabyLogisticRegressionVariablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24 

---

### Chunk 14/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.520

iablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24‚Äì2.51)0.69Milkconsumption(novs.high)1.39(0.57‚Äì3.34)0.466.32(1.04‚Äì38.29)0.045DHEA(ng/ml)0.75(0.61‚Äì1.05)0.060.73(0.51‚Äì0.96)0.032T20.89(0.63‚Äì1.24)0.620.78(0.44‚Äì2.22)0.72E20.67(0.33‚Äì2.65)0.580.90(0.46‚Äì3.12)0.65PTH(pg/ml)1.01(0.97‚Äì1.04)0.640.97(0.90‚Äì1.04)0.3625OHD(ng/ml)0.98(0.93‚Äì1.07)0.220.51(0.11‚Äì0.82)0.047CTX(pg/ml)1.02(0.98‚Äì1.05)0.171.02(0.92‚Äì1.12)0.78PINP(ng/ml)1.12(0.97‚Äì1.48)0.511.07(0.95‚Äì1.17)0.31Follistatin(ng/ml)1.08(0.56‚Äì2.09)0.171.66(1.19‚Äì3.57)0.022Myostatin(ng/ml)0.95(0.90‚Äì1.13)0.821.01(0.98‚Äì1.03)0.56BDNF(ng/ml)0.78(0.38‚Äì1.62)0.500.35(0.07‚Äì1.82)0.35Oxytocin(pg/ml)0.75(0.63‚Äì0.98)0.0190.88(0.57‚Äì1.01)0.14Multivariatelogisticanalysiswasperformedafteradjustingforage.DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagenc

---

### Chunk 15/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.519

ratorymuscletraininginseverelydisabled
multiplesclerosispatients.ArchPhys
MedRehabil2000:81:747‚Äì751.GreenJS,StanforthPR,RankinenT,LeonAS,RaoDD,SkinnerJS,
BouchardC,WilmoreJH.The
effectsofexercisetrainingonabdominalvisceralfat,bodycomposition,andindicatorsofthe
metabolicsyndromein54Pedersen&Saltin
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

postmenopausalwomenwithandwithoutestrogenreplacementtherapy:theHERITAGEfamily
study.Metabolism2004:53:1192‚Äì1196.GreenRH,SinghSJ,WilliamsJ,MorganMD.Arandomised
controlledtrialoffourweeksversussevenweeksofpulmonaryrehabilitationinchronicobstructive
pulmonarydisease.Thorax2001:56:
143‚Äì145.GrifÔ¨ÅthsTL,BurrML,CampbellIA,Lewis-JenkinsV,MullinsJ,ShielsK,
Turner-LawlorPJ,PayneN,
NewcombeRG,IonescuAA,ThomasJ,TunbridgeJ,LonescuAA.Resultsat1yearofoutpatient
multidisciplinarypulmonaryrehabilitation:arandomisedcontrolledtrial.Lancet2000:355:
362‚Äì368.GrifÔ¨ÅthsTL,Philli

---

### Chunk 16/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.517

composition with metabolism and disease. J Nutr Health Aging 2005;9:408‚Äì419
86. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in
community-dwelling older men and women: Findings from the MacArthur Foundation
Research Network on Successful Aging. 
J Clin Epidemiol 1993;46:1129‚Äì1140
87. Morrison MF, Katz IR, Parmelee P et al. 
Dehydroepiandrosterone sulfate (DHEA-S) and
psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr
Psychiatry 1998;6:277‚Äì284
88. Abbasi A, Duthie EH, Sheldahl L et al. Association of dehydroepiandrosterone sulfate,
body composition, and physical fitness in independent communitydwelling older men and
women. J Am Geriatr Soc 1998;46:263‚Äì273
89. Clarke BL, Ebeling PR, Jones JD, Wahner HW, O‚ÄôFallon WM, Riggs BL, Fitzpatrick LA.
Predictors of bone mineraldensity in aging healthy men varies by skeletal site. Calcified Tiss
Int 2002;70:137‚Äì145
90.

---

### Chunk 17/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.516

toexercisetrainingstatusandsex.Age(Dordr).2013;35(2):395‚Äì405.https://doi.org/10.1007/s11357-011-9345-y.36.Alem√°n-MateoH,Carre√≥nVR,Mac√≠asL,Astiazaran-Garc√≠aH,Gallegos-AguilarAC,Enr√≠quezJR.Nutrient-richdairyproteinsimproveappendicularskeletalmusclemassandphysicalperformance,andattenuatethelossofmusclestrengthinoldermenandwomensubjects:asingle-blindrandomizedclinicaltrial.ClinIntervAging.2014;9:1517‚Äì25.https://doi.org/10.2147/CIA.S67449.37.GranicA,HurstC,DismoreL,AsprayT,StevensonE,WithamM,etal.Milkforskeletalmusclehealthandsarcopeniainolderadults:anarrativereview.ClinIntervAging.2020;15:695‚Äì714.https://doi.org/10.2147/CIA.S245595.Publisher‚ÄôsNoteSpringerNatureremainsneutralwithregardtojurisdictionalclaimsinpublishedmapsandinstitutionalaffiliations.
Duetal.BMCGeriatrics         (2021) 21:542 Page10of10

---

### Chunk 18/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.513

stratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05‚Äì0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63‚Äì0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.fracture)(OR0.45;95%CI0.01‚Äì0.86;p=0.015),milkconsumption(novs.high)(OR6.32;95%CI1.04‚Äì38.29;p=0.045),DHEA(OR0.73;95%CI0.51‚Äì0.96;p=0.032),follistatin(OR1.66;95%CI1.19‚Äì3.57;p=0.022)and25OHD(OR0.51;95%CI0.11‚Äì0.82;p=0.047)wereassociatedwithsarcopenia(Table4).DiscussionsUsingcohortsofcommunity-dwellingpostmenopausalwomeninShanghai,China,weexaminedtherelation-shipbetween13circulatingbiomarkers,includingDHEA,E2,T2,LH,FSH,myostatin,follistatin,oxytocin,BDNF,CTX,PINP,PTHand25OHD,andbonemass,musclemass,strengthandfunctiontoevaluatetheprac-ticalvalueofthesebiomarkersinclinicalpractice.FollistatinpositivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwi

---

### Chunk 19/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.513

.140.24WHR(waist/hip)1.09¬±0.161.11¬±0.141.09¬±0.130.76Fatmass(kg)20.91¬±4.520.73¬±4.419.63¬±5.20.50Leanmass(kg)38.06¬±4.536.82¬±3.634.24v4.40.001ASMI(kg/m2)6.25¬±0.716.18¬±0.565.92¬±0.870.13LHLuteinizinghormone,FSHFolliclestimulatinghormone,DHEADehydroepiandrosterone,E2Estradiol,T2Testosterone,P1NPN-terminalpropeptideoftypeIcollagen,CTXCross-linkedC-telopeptideoftypeIcollagen,PTHParathyroidhormone,25OHDSerum25(OH)D,BDNFBrain-derivedneurotrophicfactor,BMIBodymassindex,BMDBonemineraldensity,WHRWaist/hipratio,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page5of10

inducedbylowmusclemassandfunction.However,highfollistatininhibitsmyostatin-mediatedmusclewast-ing[20].Wealsofoundthatmyostatinpositivelycorre-latedwithfatmass.Severallinesofevidencesuggestthatobesityposesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecr

---

### Chunk 20/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.511

BDNF(ng/ml)22.67¬±13.330.75¬±10.628.74¬±7.830.80¬±10.90.265Oxytocin(pg/ml)398.3(173.2‚Äì662.6)425.8(200.2‚Äì702.3)500.4(289.3‚Äì823.4)612.7(356.2‚Äì1276.5)0.022BMD(g/cm2)LumbarSpine0.703¬±0.150.695¬±0.060.895¬±0.090.886¬±0.08<0.001FemoralNeck0.579¬±0.090.612¬±0.100.648¬±0.060.659¬±0.100.019TotalHip0.722¬±0.100.748¬±0.110.767¬±0.090.816¬±0.130.007BMI(kg/m2)19.41¬±1.923.96¬±3.320.31¬±1.925.09¬±2.6<0.001Fatmass(kg)15.50¬±2.320.86¬±4.918.59¬±5.121.43¬±4.00.001Leanmass(kg)30.43¬±2.436.99¬±3.832.87¬±3.138.27¬±3.8<0.001ASMI(kg/m2)4.92¬±0.26.22¬±0.54.96¬±0.36.44¬±0.5<0.001OSOsteosarcopenia,OPOsteoporosis,SPSarcopenia,NonSP/NonOPNosarcopenianoosteoporosis,DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagencrosslinks,P1NPN-terminalpropeptideoftype1collagen,BDNFBrain-derivedneurotrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChi

---

### Chunk 21/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.510

os/semana (aer√≥bio moderado) e fortalecimento 2 dias/semana.
- Perda m√©dia m√°xima observada no grupo controle foi de ~2%, ilustrando limita√ß√£o das diretrizes padr√£o sem abordagens mais intensivas ou individualizadas.
**Prote√ß√£o de massa magra deve ser prioridade em qualquer estrat√©gia de emagrecimento.**
- √â considerado toler√°vel perder at√© 25% da massa magra relativa √† perda total de peso; an√°lises por DEXA relatam m√©dia de 40% em alguns contextos, excedendo o limite.
- Exemplo: perder 10 kg com 40% de massa magra perdida implica 4 kg de massa magra, enquanto o toler√°vel seria 2,5 kg‚Äîindicando risco significativo se n√£o houver suporte de treino de for√ßa e prote√≠na adequada.
**Achados Adicionais**
- Popula√ß√£o do estudo de tirzepatida por sexo: 265 homens e 140 mulheres; total randomizado 405 pacientes em um contexto citado.

---

### Chunk 22/30
**Article:** Mastologia II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.510

dos sintomas gerais a investigar em consulta, como dor mam√°ria e TPM intensa, que podem indicar predomin√¢ncia estrog√™nica.

## Objetivo:
N√£o h√° achados de exame f√≠sico de um paciente espec√≠fico. A abordagem objetiva descrita inclui:
- Avalia√ß√£o da composi√ß√£o corporal por bioimped√¢ncia ou densitometria de corpo total, identificando condi√ß√µes como sarcopenia em mulheres com peso normal.
- Solicita√ß√£o de exames laboratoriais para avaliar marcadores inflamat√≥rios e verificar se a paciente est√° metabolicamente doente ou em risco.

## Diagn√≥stico Prim√°rio:
- Avalia√ß√£o: Discuss√£o educacional sobre estratifica√ß√£o de risco para c√¢ncer de mama. 90% dos casos relacionam-se ao estilo de vida e 10% a fatores gen√©ticos conhecidos. Muta√ß√µes de alta penetr√¢ncia (ex.: BRCA1, BRCA2, TP53) aumentam significativamente o risco, por√©m s√£o raras. Epigen√©tica e estilo de vida s√£o cruciais e modific√°veis.

---

### Chunk 23/30
**Article:** Fisiologia do Horm√¥nio do Crescimento Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.510

hormonais; poss√≠vel benef√≠cio de reposi√ß√£o de GH quando h√° defici√™ncia documentada.
## Objetivo:
- N√£o h√° dados objetivos de exame f√≠sico, resultados laboratoriais individuais, nem achados de imagem de um paciente espec√≠fico; conte√∫do √© educacional e de revis√£o.
- Revis√£o de estudos cl√≠nicos:
  - Homens jovens treinados: GH 0,04 mg/kg, 5 dias/semana, n√£o aumentou hipertrofia nem for√ßa com treino resistido.
  - Indiv√≠duos mais velhos: GH + treino n√£o aumentou s√≠ntese proteica; resultados semelhantes aos jovens.
  - GH isolado, em doses fisiol√≥gicas e suprafisiol√≥gicas (7‚Äì14 UI em alguns estudos), n√£o promoveu atividade anab√≥lica muscular significativa.
  - Aumento consistente de massa livre de gordura com GH, majoritariamente por reten√ß√£o h√≠drica (reabsor√ß√£o de s√≥dio tubular), sem ganho de for√ßa ou s√≠ntese miofibrilar.

---

### Chunk 24/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.509

edandtheshortphysicalperformancebat-tery(SPPB).Techniciansgenerallydecidewhetherthetestcanbecompletedandthecompletiontime,whichcreatesacertainbias.Third,osteoporosisandsarcopeniaarechronicdiseases,andnotallindividualsexhibitthesameratesofmuscleandboneloss.Therefore,corre-spondingindicatorstotrackprogressionovertimeortheresponsetointerventionsareimportantandneces-sary.Toovercometheshortageofcurrentlyavailabletechniquestoevaluatemuscleandbone,apoolofserumbiomarkerswasrecentlydevelopedbasedonthemo-lecularbiologicalmechanismsoftheirinvolvementinthepathogenesisofsarcopeniaandosteoporosis,suchasendocrinesystem,growthfactors,andmuscleproteinturnover.Biomarkers,whichtheoreticallyaffectthesemechanisms,maypredictorreflectthestateofbonesandmuscles[5,6].However,whetherthesebiomarkerstrulyreflectthestateofbonesandmuscleswasnotveri-fied.Toexploretherelationshipbetweenbiomarkersandbonesandmuscles,weidentifiedbiomarkersofosteoporosisandsarcopeniaaccordingtodifferentpathophysiologicalmechanisms.(1)Myok

---

### Chunk 25/30
**Article:** Bioqu√≠mica Metab√≥lica nos Exerc√≠cios - Parte III (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.508

a n√£o consensual; dose pr√°tica 1 g 3x/dia.
### 13. Hipertrofia: inflama√ß√£o e modula√ß√£o
- Hipertrofia depende de sobrecarga mec√¢nica, microles√µes, grande processo inflamat√≥rio e aumento de s√≠ntese proteica.
- IL-6, ERO e lactato s√£o sinaliza√ß√µes √∫teis; evitar anti-inflamat√≥rios/crioterapia e excesso de antioxidantes imediatamente ap√≥s.
- Demandas proteicas aumentam com VO2, intensidade e frequ√™ncia.
### 14. D√©ficit energ√©tico cr√¥nico e sinais cl√≠nicos
- Indicativos: am√¥nia, ureia, √°cido √∫rico, transaminases, cortisol altos; queda de performance e de massa; desidrata√ß√£o; pior recupera√ß√£o.
- Sinais: queda de cabelo, unhas quebradi√ßas, imunidade baixa; bioimped√¢ncia mostra altera√ß√µes de √°gua; poss√≠vel aumento de TSH e queda de T3 por d√©ficit energ√©tico (pseudo-hipotireoidismo).
- Hipertrofia invi√°vel sob catabolismo salvo interven√ß√µes hormonais n√£o-mTOR com resultados limitados.
### 15.

---

### Chunk 26/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.507

atmayleadtoahighesti-matedriskoffracturesandalowqualityoflifeintheelderlypopulation[1].Approximately212millionpeoplewillsufferfromosteoporosis,andthetotalnumberofhipfracturesisforecasttoreach3.25millioninChinaby2050[2].Becauseoftheseverityoftheconsequences,earlyscreeninganddiagnosis,preventionandinterven-tionforosteoporosisandtheriskoffractureareofgreatimportance.However,theclinicaldiagnosisishamperedbythreekeydifficultiesintheevaluationofmuscleandbonesta-tus.First,dual-energyX-rayabsorptiometry(DXA),magneticresonanceimaging(MRI)andcomputedtom-ography(CT)imagingmodalitiesprovideanobjectiveandsufficientlyreliableestimationofbodycomposition[3].However,theseimagingtechniquesaretechnically
¬©TheAuthor(s).2021OpenAccessThisarticleislicensedunderaCreativeCommonsAttribution4.0InternationalLicense,whichpermitsuse,sharing,adaptation,distributionandreproductioninanymediumorformat,aslongasyougiveappropriatecredittotheoriginalauthor(s)andthesource,providealinktotheCreativeCommonslicence,andindicat

---

### Chunk 27/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.506

nsecretioninamenorrheicathleteswasstronglyassociatedwithachangeinbonearchitectureaftercontrollingforestradiol[32],whichsuggeststhatoxytocinplaysaroleintherescueofbonemetabolisminpostmenopausalwomenwithlowestrogenlevels.Osteoporosis,sarcopeniaandosteosarcopeniaarecommonskeletalandmusclediseasesintheelderly.Tofurtherverifytheclinicalapplicationvalueofbio-markers,wecomparedserumbiomarkerlevelsinthe
Table2Multivariablelinearregressionevaluatingbiomarkerslinkingtomusclestrength,musclemass,fatmassandbonemassadjustedforageHandgrip(right)R2beta95%CIPvalueDHEA0.6110.4030.352~0.4540.041T20.005‚àí1.224‚àí4.6854-2.2360.484E20.002‚àí0.013‚àí0.078-0.0510.682Gaitspeedbeta95%CIPvalueDHEA0.2340.580.576~0.5870.004T20.006‚àí1.198‚àí4.389-1.9930.458E20.0020.013‚àí0.046-0.0730.657Leanmassbeta95%CIPvalueFollistatin0.365‚àí0.28‚àí0.309~‚àí0.2430.010Oxytocin0.2720.350.306~0.3980.036Fatmassbeta95%CIPvalueMyostatin0.3620.920.881~0.9600.021ASMIbeta95%CIPvalueMyostatin0.356‚àí0.31‚àí0.352~‚àí0.2510.032Follistatin

---

### Chunk 28/30
**Article:** Aula J√©ssica Marques - Neurologia Funcional Integrativa 3 (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.505

agn√©sio, vitamina B12, folato (B9), vitamina D e ferritina/ferro; corrigir defici√™ncias conforme resultados.
- [ ] 3. Planejar introdu√ß√£o gradual de suplementa√ß√£o: iniciar uma formula√ß√£o, aguardar 2‚Äì3 dias, adicionar a segunda e, ap√≥s 2‚Äì3 dias, a terceira, monitorando efeitos colaterais.
- [ ] 4. Implementar ciclos de 60‚Äì90 dias entre plantas com mecanismos semelhantes, trocando para outra fam√≠lia ap√≥s cada ciclo para sensibilizar diferentes receptores.
- [ ] 5. Selecionar extratos padronizados com maior biodisponibilidade (ex.: Curcumin C3, Cureit, CurcuVail) e evid√™ncia cl√≠nica para compor formula√ß√µes.
- [ ] 6. Incorporar vias alternativas para idosos: avaliar uso de injet√°veis, transd√©rmicos, fotobiomodula√ß√£o, aromaterapia e tinturas conforme perfil e poder aquisitivo.
- [ ] 7. Estruturar rotina di√°ria do paciente com atividades √∫teis e significativas (cozinhar, organizar casa, acompanhar netos/filhos), promovendo pertencimento e utilidade.
- [ ] 8.

---

### Chunk 29/30
**Article:** Emagrecimento - Parte I (2024)
**Journal:** Pos Graduacao MFI
**Section:** methods | **Similarity:** 0.505

s com peso normal se enquadram nessa categoria.
*   **M√©todos de Avalia√ß√£o Adequados**
    - Composi√ß√£o corporal deve ser avaliada por dobras cut√¢neas ou bioimpedanciometria.
    - Dois indiv√≠duos com mesmo peso e altura (mesmo IMC) podem ser metabolicamente opostos: um predomin√¢ncia de gordura, outro de m√∫sculo.
*   **Cirurgia Bari√°trica como Recurso**
    - V√°lida, por√©m √∫ltimo recurso ap√≥s esgotar outras tentativas.
    - Cirurgias aumentaram 85% (2011‚Äì2018): 60% bypass e 36% sleeve.
    - Critica pr√°tica anti√©tica de orientar ganho de peso para qualificar pelo conv√™nio.
    - P√≥s-bari√°tricos enfrentam riscos como alcoolismo, depress√£o e suic√≠dio; necessitam acompanhamento multidisciplinar e funcional, raramente realizado.

## ‚ùì Perguntas
- [Inserir Pergunta/Confus√£o]

## üìö Tarefas
- [ ] 1. Refletir sobre a pr√°tica profissional no emagrecimento e identificar lacunas de conhecimento (fisiologia, intestino, mitoc√¥ndrias, inflama√ß√£o, etc.).
- [ ] 2.

---

### Chunk 30/30
**Article:** Mastologia I (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.505

est√£o associadas a um aumento dr√°stico no risco de mortalidade em pacientes com c√¢ncer.**
- Mulheres com hiperinsulinemia apresentaram um risco 34% maior de desenvolver c√¢ncer e um risco 78% maior de morte ap√≥s o diagn√≥stico, independentemente do IMC ou da circunfer√™ncia abdominal.
- Pacientes com sarcopenia (perda de massa muscular) tiveram um aumento de 93% nas mortes por c√¢ncer em geral e, especificamente em casos de c√¢ncer de mama, a mortalidade foi 41% maior.
- Uma meta-an√°lise tamb√©m mostrou que a sarcopenia aumentou em 44% as mortes por todas as causas.
**A m√©trica de "sobrevida em 5 anos", embora comum em oncologia, pode ser enganosa devido a vieses estat√≠sticos relacionados ao momento do diagn√≥stico.**
- A sobrevida em 5 anos √© uma m√©trica frequentemente usada para avaliar a efic√°cia percebida do rastreamento mamogr√°fico.

---

